New technology may be able to help ODs’ most challenging patient segment
April digital edition 2021
This drug category is rapidly growing in the ophthalmic space, with more options in the pipeline
Explore the risks and benefits of different approaches to virus vaccination
Closely monitor patient over time for continued corneal health and good fit
quick quiz on fitting scleral lenses
An FDA-approved drop would be a game changer in the treatment of Demodex blepharitis
Find out which myths are busted and which are plausible
The technology can diagnose age-related macular degeneration and diabetic retinopathy
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
“Family business?” Navigating the business of treating family
2
Ortho-k: More than meets the eye to control myopia progression
3
ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA
4
Improved grading scales for oncology drugs causing ocular adverse events
5
.png "Optometry Times"){kind=logo}
